A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2011
08/09/2011	US7994283 Dimeric proteins for immunization
08/09/2011	US7994282 Card proteins involved in cell death regulation
08/09/2011	US7994278 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
08/09/2011	US7994276 Composition of tumour-associated peptides and related anti-cancer vaccine
08/09/2011	US7994212 For therapy of of neoplastic diseases
08/09/2011	US7994151 Compositions and methods for angiogenic therapy utilizing genes encoding ets-1
08/09/2011	US7994147 Cellular genes regulated by HIV-1 infection and methods of use thereof
08/09/2011	US7994146 Method of enhancing an immune response
08/09/2011	US7994144 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme
08/09/2011	US7994138 Microbial biosurfactants as agents for controlling pests
08/09/2011	US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy
08/09/2011	US7994136 Metalloproteinase inhibitor
08/09/2011	US7994135 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases
08/09/2011	US7994134 Peptide-based compounds
08/09/2011	US7994133 Isozyme-specific antagonists of protein kinase C
08/09/2011	US7994132 polypeptides that stimulate the formation and cycling of pre-beta high density lipoproteins, promote lipid transport and detoxification, inhibit osteoporosis and atherosclerosis, intensify the activity anticholesterol agents, causing them to be significantly more antiinflammatory at any given dosage
08/09/2011	US7994131 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
08/09/2011	US7994130 Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability
08/09/2011	US7994129 Methods of using black bear parathyroid hormone
08/09/2011	US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters
08/09/2011	US7994127 Treatment of rett syndrome
08/09/2011	US7994126 Treatment of cellular proliferative disorders with compositions comprising Hom polypeptide (also known as Xom, VENTX2)
08/09/2011	US7994125 Administered before,during or after chemotherapy
08/09/2011	US7994124 Using granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine mutein as therapeutic in treatment of neutropenia
08/09/2011	US7994123 Polypeptides; hybrid nucleic acids; anticancer agents; central nervous system disorders
08/09/2011	US7994122 Glucagon analogues
08/09/2011	US7994121 Stable analogs of peptide and polypeptide therapeutics
08/09/2011	US7994120 Method of treating dyslipidemic disorder
08/09/2011	US7994119 Compounds for control of appetite
08/09/2011	US7994118 Template fixed beta-hairpin loop mimetics and their use in phage display
08/09/2011	US7994117 Thrombopoietic compounds
08/09/2011	US7994116 Methods for reduction of adhesion formation using cytokine inhibitors
08/09/2011	US7994115 Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
08/09/2011	US7994114 Chemokine mimetics synthesis and their use
08/09/2011	US7993919 Method of inducing memory B cell development and terminal differentiation
08/09/2011	US7993901 Nitrilases and methods for making and using them
08/09/2011	US7993857 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith
08/09/2011	US7993845 ACPL-related assays
08/09/2011	US7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy
08/09/2011	US7993829 HPRP4s modifiers of the p53 pathway and methods of use
08/09/2011	US7993679 Flowable wound matrix and its preparation and use
08/09/2011	US7993672 Stable lipid-comprising drug delivery complexes and methods for their production
08/09/2011	US7993665 Pro-angiogenic protein 156A, also called Angiodensine which stimulates migration of endothelial cells; use treating chronic or acute wounds
08/09/2011	US7993659 TLR9 agonist and CD40 agonist immunostimulatory combinations
08/09/2011	US7993651 Administering gag protein; vaccines for human immunodeficiency virus
08/09/2011	US7993650 Polypeptides having binding affinity for HER2
08/09/2011	US7993648 Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
08/09/2011	US7993641 Methods of treatment using anti-CD3 antibodies
08/09/2011	US7993639 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/09/2011	US7993638 Cancer treatment combining lymphodepleting agent with CTLs and cytokines
08/09/2011	US7993637 IL-11 muteins
08/09/2011	US7993636 Tumor necrosis factor-alpha mutants
08/09/2011	US7993627 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening
08/09/2011	CA2664300C Agent for preventing onset of post-stroke reflex sympathetic dystrophy
08/09/2011	CA2634664C Novel albumin-free factor viii formulations
08/09/2011	CA2474645C Compositions and methods for systemic inhibition of cartilage degradation
08/09/2011	CA2450179C Identification of stat6 modulators using ncoa-1/stat6 interaction
08/09/2011	CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
08/09/2011	CA2438092C Ttk in diagnosis and as a therapeutic target in cancer
08/09/2011	CA2431842C Method for preparing tryptophan rich peptides
08/09/2011	CA2422078C High efficiency cardiac gene transfer
08/09/2011	CA2380058C Novel peptides
08/09/2011	CA2370738C Uteroglobin in the treatment of iga mediated autoimmune disorders
08/09/2011	CA2367360C Insulin-like growth factor binding protein-4 protease
08/09/2011	CA2366462C Two-step immunization procedure against chlamydia infection
08/09/2011	CA2350340C B-cell epitopes of hsp65 and uses thereof
08/09/2011	CA2334941C Tnf-derived peptides for use in treating oedema
08/09/2011	CA2332115C Aav structural protein, its preparation and use
08/09/2011	CA2267210C Method of stabilizing useful protein and useful protein composition
08/09/2011	CA2253240C Hereditary hemochromatosis gene
08/09/2011	CA2243559C Pharmaceutical composition for immunomodulation
08/09/2011	CA2237995C Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
08/09/2011	CA2205075C Reagent and method for inhibition of n-ras expression
08/09/2011	CA2146328C C-c ckr-1, c-c chemokine receptor
08/04/2011	WO2011094722A1 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
08/04/2011	WO2011094671A2 N-terminally conjugated polypeptides for targeted therapy and diagnosis
08/04/2011	WO2011094632A1 Method for administration of insulin and pharmaceutical composition thereof
08/04/2011	WO2011094536A1 Method for treating liver disorders with receptor associated protein ( irp) peptide-fucosidase inhibitor conjugates
08/04/2011	WO2011094446A1 A method for treating brain cancer using a novel tumor suppressor gene and secreted factor
08/04/2011	WO2011094445A1 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
08/04/2011	WO2011094430A2 Pro-angiogenic fragments of prominin-1 and uses thereof
08/04/2011	WO2011094426A1 Caspase inhibitors
08/04/2011	WO2011094352A1 In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation
08/04/2011	WO2011094337A1 Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
08/04/2011	WO2011094137A1 Methods of treating glucose metabolism disorders
08/04/2011	WO2011094136A1 Methods of treating glucose metabolism disorders
08/04/2011	WO2011093932A2 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains
08/04/2011	WO2011093851A1 Method for treatment of vascular hyperpermeability
08/04/2011	WO2011093710A1 Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
08/04/2011	WO2011093693A1 Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
08/04/2011	WO2011093647A2 Genes implicated in osteoarthritis and use thereof
08/04/2011	WO2011093509A1 Polynucleotide encoding acyl-coa synthetase homolog and method for using the same
08/04/2011	WO2011093498A1 Loxoprofen-containing pharmaceutical composition
08/04/2011	WO2011093470A1 Pharmaceutical composition for treatment of bone diseases, which contains protein comprising bone morphogenetic protein receptor 1b (bmpr1b) extracellular domain or mutant thereof
08/04/2011	WO2011092347A1 Oligopeptidic compounds and uses thereof
08/04/2011	WO2011092231A1 Cytokines for the treatment of addictions
08/04/2011	WO2011092199A1 Mutated xmrv env proteins in the immunosuppressive domain
08/04/2011	WO2011092181A1 Screening method for identifying compounds which block tumour growth by inducing irreversible senescence in tumour cells
08/04/2011	WO2011091807A1 Anticoagulant and glutathione for treatment of cancer
08/04/2011	WO2011091723A1 Neuregulin based compositions and uses thereof for preventing, treating or delaying the myocardial ischemia-reperfusion injury

1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 3163